High-Dose Therapy Before Transplant Effective in Refractory Myeloma
Undergoing autologous hematopoietic stem cell transplantation was effective and safe in patients with refractory multiple myeloma, including those patients who are refractory to both proteasome inhibitors and immunomodulatory agents.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Multiple Myeloma News Source Type: news
More News: Cancer & Oncology | Hematology | Legislation | Myeloma | Stem Cell Therapy | Stem Cells | Transplants